Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2022 | 2023 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$149.4K | −$156.6K |
| EBITDA | −$149.4K | −$156.6K |
| Net income | −$149.4K | −$151.3K |
| Net margin | — | — |
| EPS (diluted) | -0.00 | -0.03 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ROCAF.
No tracked institution reports a position in ROCAF as of their last filing.
No one on the platform has traded ROCAF yet.
| $2805 |
| — |
| KWBTKiwa Bio-Tech Products Group Corporation | $0.00 | +0.00% | $56477 | — |
| NSMCFNorthern Sphere Mining Corp. | $0.00 | +0.00% | $51278 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.